Update September 16. The Pfizer BioNTech and Moderna vaccines have been granted complete acceptance in Health Canada, and new brand names were introduced. It’s now the Pfizer BioNTech vaccine. It is now “Comirnaty,” the Moderna vaccine is now “SpikeVax,” and the AstraZeneca vaccine is now referred to in the form of “Vaxzevria.”
In this outbreak and over in the last few months, we’ve been working on COVID-19 vaccination education. We have presented the latest research findings and dispelled the myths that are detrimental to our children’s health. We have recently reviewed the Moderna for the COVID-19 vaccine by Pfizer.
There have been a lot of inquiries on social media and Zoom Q&A inquiries concerning using the Pfizer COVID-19 vaccine as the most popular vaccine. We’ve also witnessed a lack of enthusiasm for — and at times, complete refusal of the Moderna vaccine. The issues can range from comparing adverse side effects that result from vaccination to speculation about potential supply chain issues with supply chain problems with the Moderna vaccine. To help clear any confusion, we’ve used the results of scientific research. Here’s what you need to know about the similarities and differences between Moderna and Pfizer COVID-19 shots and the considerations with buying vaccines.
To help clear any confusion with data derived from research studies, here are the facts you need to be aware of the differences and similarities between Moderna and Pfizer COVID-19 shots and the challenges of purchasing photos.
Two Moderna and Pfizer COVID-19 vaccines utilize identical messenger RNA (mRNA) technology to protect against the COVID-19 virus, which is caused by the SARS CoV-2 virus. They differ in the chemical composition of sugars, lipids, and salts that help ensure the mRNA’s integrity. These differences impact the storage requirements but not the efficacy the effectiveness of vaccines.
The mRNA in the Pfizer and Moderna vaccines contains the genetic code for the spike protein. This protein is found within the outer layer of the virus. The two vaccines teach your body to recognize spike proteins, ensuring that your immune system can swiftly fight a SARS-CoV-2 virus, thereby avoiding severe illness, hospitalization, and death.
Clinical trials have demonstrated that Moderna, along with Pfizer, is highly effective (94.1 percent and 94.1, respectively) in reducing the signs of COVID-19. Both vaccines are of equal effect in preventing severe disease and death due to COVID-19.
In the worldwide campaign to be vaccinated worldwide, the two vaccines Pfizer and Moderna, have been very efficient in preventing COVID-19-related illnesses. For instance, a large study by U.S. Healthcare professionals discovered that the probability of being positive for SARS-CoV-2 is 98.6 percent smaller for healthcare professionals completely vaccinated with the Moderna vaccine and 96.8 percent lesser for those for who Pfizer vaccine had fully been vaccinated.
More than 30,000 people were involved within Phase Three trials of the Moderna COVID-19 vaccination. Over 40,000 patients were involved in the COVID-19 vaccination trial conducted by Pfizer. The following is a graphic of the most commonly reported adverse incidents (i.e., adverse reactions) for both doses of Moderna or Pfizer vaccines. These include discomfort in the injection sites as well as fatigue. These results were published in the Canadian monographs for the product in which details about the medications are distributed to healthcare professionals and the general public.
This isn’t an exhaustive list. This information reveals commonalities among post-vaccine adverse effects, which tend to be resolved within several days. It’s challenging to determine each person’s response to vaccinations. But, it’s essential to be aware that these reactions are generally minor and typically indicate the activation of our immune system. While some people may experience these adverse reactions, the majority do not.
The Canadian government follows a strict policy for reporting adverse consequences. In Canada, a myriad of COVID-19-related adverse effects is documented and recorded as part of regular safety surveillance. In the over five million Moderna doses of the vaccine administered to patients, only 0.04 percent of those who had been vaccinated experienced minor side effects such as headache or fatigue. Just 0.003 percent reported serious side consequences, such as anaphylactic reaction. Of the 18 million Pfizer vaccine doses administered in the past, only 0.02 percent of the vaccine recipients said no adverse negative side effects. Only 0.005 percent reported having severe adverse reactions.
The adverse reactions mentioned previously are usually minor, but severe adverse effects are uncommon. This is in line with the very few negative side effects reported among the millions of Canadians.
Canada is growing its vaccinations. This has the most recent delivery of 7.1 million doses of Moderna that will be paid in June. To better comprehend the availability of vaccines in Canada, the table below by the federal government gets updated every week. It includes details on the allocation and allocation of COVID-19 vaccines and information on what is demanded to be administered of the two mRNA-based vaccines.
Suppose there isn’t a vaccine on the market for the second dose. In this case, there is a recommendation from NACI that suggests that you use a different vaccine. On Immunization (NACI) recommends that you choose an alternative mRNA vaccine to be administered as an extra dose. But, there’s no reason to believe a follow-up dosage of the Moderna vaccine will be available to patients given the vaccine in the initial amount.
Pfizer is gaining better awareness in current times, as research conducted by The U.K. found two doses of their vaccines have an efficiency of 88 percent in preventing the delta variant of infection. Research from those in the U.K., Spain, and Germany has also verified the immune response’s safety and strength after receiving a second dose of Pfizer following the dosage of AstraZeneca. We’re awaiting news on Moderna. Moderna vaccine is in this situation because of its similar characteristics and outcomes; Moderna is expected to be just as efficient as Pfizer in all aspects.
Moderna and Pfizer COVID-19 vaccines’ mRNAs are both safe and effective in stopping COVID-19 death within the pathways. Pfizer is more popular than Moderna and may get brand recognition. However, they are both identical to ours.
They work the same way and may have similar adverse consequences. We are aware that these side effects are most relevant to those who do not use paid sick days if ailments hinder their ability to do their job. According to current trends, this distribution in Canada is likely to change and flow. But, every person who lives in Canada can be assured of receiving the second shot.
Your vaccine administrator or public health center will be able to advise you on the best method for you to get treated. The delay in obtaining vaccinations in hopes of receiving a “preferred” brand may put one at risk of contracting COVID-19, particularly with the increase in the Delta variant. This form of vaccination is more transmissible and may cause more infections even after one dose. Based on the research to the contrary, instead of debating over Pfizer and Moderna, having the first COVID-19 vaccine once you’re competent is the best decision you can take.
Mira Maximos is the Antimicrobial Stewardship Pharmacy Director for Woodstock Hospital in Ontario. She is also an investigator in the Centre of Excellence for Women’s Health and Knowledge Mobilization pharmacist from Spectrum Mobile Health.